NCT00311350View on ClinicalTrials.gov

Study Evaluating the Safety of MOA-728 Administered Orally to Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

March 31, 2006

Study Completion Date

August 31, 2006

Conditions
Postoperative ComplicationsConstipation
Interventions
DRUG

MOA-728

Trial Locations (1)

19148

Philadelphia

All Listed Sponsors
lead

Bausch Health Americas, Inc.

INDUSTRY

NCT00311350 - Study Evaluating the Safety of MOA-728 Administered Orally to Healthy Subjects | Biotech Hunter | Biotech Hunter